2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference
05 11월 2024 - 6:01AM
Business Wire
2seventy bio, Inc. (Nasdaq: TSVT) will announce its third
quarter 2024 financial results on Tuesday, November 12, 2024. A
conference call and webcast will be held at 8:00 a.m. ET.
Participants can access the financial results conference call
live via webcast which will be available on the Investors and Media
page of the company’s website at https://ir.2seventybio.com.
Participants who wish to ask a question may register here to
receive dial-in numbers and a unique pin to join the call. It’s
recommended that participants join 10 minutes prior to the event’s
start.
Members of the management team will also be presenting at the
following upcoming investor conference:
- Guggenheim’s Inaugural Healthcare Innovation Conference in
Boston, MA on Wednesday, November 13, 2024 at 10:00 a.m. ET
A live webcast of the fireside chat will be available via the
Investors and Media section of 2seventy bio’s website at
https://ir.2seventybio.com/. Replays will be archived on 2seventy
bio’s site for 30 days following the event.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME.
Cancer rips time away, and our goal is to work at the maximum speed
of translating human thought into action – 270 miles per hour – to
give the people we serve more time. With a deep understanding of
the human body’s immune response to tumor cells and how to
translate cell therapies into practice, we’re applying this
knowledge to deliver the first FDA-approved CAR T cell therapy for
multiple myeloma to as many patients as possible. Importantly, we
remain focused on accomplishing our mission by staying genuine and
authentic to our “why” and keeping our people and culture top of
mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and
LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241104367323/en/
Investors and Media: Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com
Morgan (Adams) Shields Morgan.adams@2seventybio.com
2seventy bio (NASDAQ:TSVT)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
2seventy bio (NASDAQ:TSVT)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
